DK128812B - Analogifremgangsmåde til fremstilling af antibakterielle N-sulfanilylcytosin-forbindelser eller alkalimetalsalte deraf. - Google Patents

Analogifremgangsmåde til fremstilling af antibakterielle N-sulfanilylcytosin-forbindelser eller alkalimetalsalte deraf.

Info

Publication number
DK128812B
DK128812B DK397566AA DK397566A DK128812B DK 128812 B DK128812 B DK 128812B DK 397566A A DK397566A A DK 397566AA DK 397566 A DK397566 A DK 397566A DK 128812 B DK128812 B DK 128812B
Authority
DK
Denmark
Prior art keywords
sulfanilylcytosine
antibacterial
compounds
preparation
alkali metal
Prior art date
Application number
DK397566AA
Other languages
Danish (da)
English (en)
Inventor
L Doub
U Krolls
Original Assignee
Parke Davis & Co
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Parke Davis & Co filed Critical Parke Davis & Co
Publication of DK128812B publication Critical patent/DK128812B/da

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/20Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members
    • C07D239/22Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having two double bonds between ring members or between ring members and non-ring members with hetero atoms directly attached to ring carbon atoms
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/47One nitrogen atom and one oxygen or sulfur atom, e.g. cytosine
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/52Two oxygen atoms
    • C07D239/54Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals
    • C07D239/545Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/557Two oxygen atoms as doubly bound oxygen atoms or as unsubstituted hydroxy radicals with other hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms, e.g. orotic acid
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/46Two or more oxygen, sulphur or nitrogen atoms
    • C07D239/56One oxygen atom and one sulfur atom
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07DHETEROCYCLIC COMPOUNDS
    • C07D239/00Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings
    • C07D239/02Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings
    • C07D239/24Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members
    • C07D239/28Heterocyclic compounds containing 1,3-diazine or hydrogenated 1,3-diazine rings not condensed with other rings having three or more double bonds between ring members or between ring members and non-ring members with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to ring carbon atoms
    • C07D239/69Benzenesulfonamido-pyrimidines

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Plural Heterocyclic Compounds (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Saccharide Compounds (AREA)
DK397566AA 1965-08-02 1966-08-01 Analogifremgangsmåde til fremstilling af antibakterielle N-sulfanilylcytosin-forbindelser eller alkalimetalsalte deraf. DK128812B (da)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
US476694A US3375247A (en) 1965-08-02 1965-08-02 Heterocyclic compounds and methods for their production

Publications (1)

Publication Number Publication Date
DK128812B true DK128812B (da) 1974-07-08

Family

ID=23892882

Family Applications (1)

Application Number Title Priority Date Filing Date
DK397566AA DK128812B (da) 1965-08-02 1966-08-01 Analogifremgangsmåde til fremstilling af antibakterielle N-sulfanilylcytosin-forbindelser eller alkalimetalsalte deraf.

Country Status (12)

Country Link
US (1) US3375247A (fr)
AT (2) AT266148B (fr)
BE (1) BE684912A (fr)
BR (1) BR6681735D0 (fr)
CH (2) CH460025A (fr)
DE (1) DE1620140C3 (fr)
DK (1) DK128812B (fr)
ES (1) ES329747A1 (fr)
FR (2) FR1488185A (fr)
GB (1) GB1089814A (fr)
SE (2) SE325030B (fr)
YU (2) YU34524B (fr)

Families Citing this family (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CH569720A5 (fr) * 1972-10-20 1975-11-28 Hoffmann La Roche
US4016267A (en) * 1974-06-19 1977-04-05 Hoffmann-La Roche Inc. Sulfacytosine derivatives
US3923792A (en) * 1974-06-19 1975-12-02 Hoffmann La Roche Sulfacytosine derivatives
CA2319592A1 (fr) 1998-02-03 1999-08-05 University Of Maryland Procede de stimulation de la production de sperme et du developpement des ovaires chez les animaux

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3249603A (en) * 1960-08-09 1966-05-03 Hoffmann La Roche Novel pyrimidine sulfanilamides and processes for their preparation

Also Published As

Publication number Publication date
BR6681735D0 (pt) 1973-10-25
GB1089814A (en) 1967-11-08
FR5929M (fr) 1968-04-01
YU145766A (en) 1979-02-28
AT266143B (de) 1968-11-11
YU160278A (en) 1979-07-10
SE325032B (fr) 1970-06-22
BE684912A (fr) 1967-01-16
DE1620140C3 (de) 1974-01-31
YU34681B (en) 1979-12-31
AT266148B (de) 1968-11-11
US3375247A (en) 1968-03-26
SE325030B (fr) 1970-06-22
ES329747A1 (es) 1967-07-16
CH460025A (fr) 1968-07-31
DE1620140B2 (de) 1973-06-14
FR1488185A (fr) 1967-07-07
DE1620140A1 (de) 1970-03-12
CH460024A (fr) 1968-07-31
YU34524B (en) 1979-09-10

Similar Documents

Publication Publication Date Title
DK114981B (da) Fremgangsmåde til fremstilling af basisk substituerede phthalaner eller iso-chromaner eller syreadditionssalte deraf.
DK113364B (da) Fremgangsmåde til fremstilling af 6,7-methylendioxy-4-oxo-3-quinolincarboxylsyrer eller alkalimetalsalte deraf.
DK117427B (da) Fremgangsmåde til fremstilling af phenoxypropanolaminer eller syreadditionssalte deraf.
DK126592B (da) Analogifremgangsmåde til fremstilling af substituerede 2-anilinopyridiner eller syreadditionssalte deraf.
DK109804C (da) Fremgangsmåde til fremstilling af basisk substituerede 2-oxobenzimidazoliner eller syreadditionssalte deraf.
DK122327B (da) Analogifremgangsmåde til fremstilling af N-alkyllincomycin D-forbindelser eller syreadditionssalte deraf.
DK129924B (da) Analogifremgangsmåde til fremstilling af aminoalkylaminobenzophenonderivater eller syreadditionssalte deraf.
DK128812B (da) Analogifremgangsmåde til fremstilling af antibakterielle N-sulfanilylcytosin-forbindelser eller alkalimetalsalte deraf.
DK124827B (da) Analogifremgangsmåde til fremstilling af carboxyacylaminopenicilliner eller salte deraf.
DK113439B (da) Fremgangsmåde til fremstilling af 1-isopropylamino-2-hydroxy-3-(o-alkoxymethyl-phenoxy)-propaner eller salte deraf.
DK115840B (da) Fremgangsmåde til fremstilling af phenylcyclohexylalkylaminer eller syreadditionssalte deraf.
DK134347B (da) Fremgangsmåde til fremstilling af krystallinske alkalimetalsalte af alfa-carboxybenzylpenicillin.
DK105462C (da) Fremgangsmåde til fremstilling af O-acetyl-3,5-dimethylbenzheparid eller alkalimetalsalte heraf.
DK123021B (da) Analogifremgangsmåde til fremstilling af syreadditionssalte af 2-aminoadamantan.
DK129934B (da) Analogifremgangsmåde til fremstilling af basiske ketoner eller syreadditionssalte deraf.
DK109600C (da) Fremgangsmåde til fremstilling af 4-p-aminobenzensulfonylamidopyrimidiner eller salte deraf.
DK109084C (da) Fremgangsmåde til fremstilling af O-methy-N-methyl-heparinamid eller dets alkalimetalsalte.
DK107287C (da) Fremgangsmåde til fremstilling af N-benzylheparinamid eller dets alkalimetalsalte.
DK126591B (da) Analogifremgangsmåde til fremstilling af 1-aralkyl-3-aryl-3-propylpyrrolidinforbindelser eller salte heraf.
DK115696B (da) Fremgangsmåde til fremstilling af 1-cycloalkylidenethyl-4-phenyl-piperidin eller syreadditionssalte heraf.
DK121171B (da) Fremgangsmåde til fremstilling af benzensulfonyl-2-amino-Δ-2-tiazolin eller -3-amino-2-iminotiazolidin eller syreadditionssalte deraf.
DK121237B (da) Fremgangsmåde til fremstilling af (alkylaminoætoksy)-dihalogenaniliner eller syreadditionssalte deraf.
DK130296B (da) Analogifremgangsmåde til fremstilling af substituerede 3-amino-4-halogen-sydnoniminsalte.
DK115544B (da) Fremgangsmåde til fremstilling af basiske dibenzocyclohepten-10-yl-ethere eller syreadditionssalte deraf.
DK122877B (da) Analogifremgangsmåde til fremstilling af fenylisopropylalkylaminderivater eller syreadditionssalte deraf.